Christopher Easley is an accomplished professional with extensive experience in market access and pricing within the life sciences sector. Currently serving as Partner and EU Market Access Lead at Blue Matter since April 2024, Christopher previously held notable positions at Oliver Wyman and Huron Consulting Group, where responsibilities included market access and pricing leadership. Christopher's career also features a significant tenure at Pope Woodhead & Associates Ltd, leading the Market Access Practice, and earlier roles at IMS Health, where contributions to product and portfolio strategy were made. Christopher began career in consulting at Cambridge Pharma Consultancy prior to its acquisition by IMS Health. Academically, Christopher holds an MSc in Chemistry from the University of Oxford.
This person is not in any teams
This person is not in any offices